Figure 1

Lipidomics screening of candidate DILD biomarkers. (A) Individual lipid plot of false discovery rate (FDR) and effect size (g) from lipidomics analyses comparing acute and recovery phase DILD patients. (B) Venn diagram of significantly different lipids between acute and recovery phase DILD patients from the screening and validation cohorts.